1367 Stock Overview
Engages in the research and development, production, and sale of chemical active pharmaceutical ingredient and intermediates in China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Zhejiang Haisen Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥24.73 |
| 52 Week High | CN¥38.51 |
| 52 Week Low | CN¥17.94 |
| Beta | 0 |
| 11 Month Change | -8.54% |
| 3 Month Change | 6.96% |
| 1 Year Change | -18.65% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -51.12% |
Recent News & Updates
Shareholder Returns
| 1367 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -4.4% | -3.7% | -1.6% |
| 1Y | -18.6% | -13.0% | -15.7% |
Return vs Industry: 001367 underperformed the CN Pharmaceuticals industry which returned -13% over the past year.
Return vs Market: 001367 underperformed the CN Market which returned -15.7% over the past year.
Price Volatility
| 1367 volatility | |
|---|---|
| 1367 Average Weekly Movement | 5.9% |
| Pharmaceuticals Industry Average Movement | 5.4% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in CN Market | 10.1% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 001367 has not had significant price volatility in the past 3 months.
Volatility Over Time: 001367's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 636 | Lin Ai | www.haisenpharma.com |
Zhejiang Haisen Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical active pharmaceutical ingredient and intermediates in China. The company offers APIs for anti-gastric ulcer, antilipemic agent, antipyretic analgesics, antidepressant, analgesic, antibacterial agent, antipyretic analgesics, histamines drug, and anticonvulsant. It also provides chemical product for intermediates and food additives.
Zhejiang Haisen Pharmaceutical Co., Ltd. Fundamentals Summary
| 1367 fundamental statistics | |
|---|---|
| Market cap | CN¥2.49b |
| Earnings (TTM) | CN¥113.05m |
| Revenue (TTM) | CN¥406.30m |
22.0x
P/E Ratio6.1x
P/S RatioIs 1367 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1367 income statement (TTM) | |
|---|---|
| Revenue | CN¥406.30m |
| Cost of Revenue | CN¥240.54m |
| Gross Profit | CN¥165.76m |
| Other Expenses | CN¥52.71m |
| Earnings | CN¥113.05m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.12 |
| Gross Margin | 40.80% |
| Net Profit Margin | 27.83% |
| Debt/Equity Ratio | 0% |
How did 1367 perform over the long term?
See historical performance and comparison